%0 Letter
%T Negative findings from trials with NLY01 or deferiprone for Parkinson's disease.
%A Müller T
%A Möhr JD
%J Lancet Neurol
%V 23
%N 6
%D 2024 Jun
%M 38760091
%F 59.935
%R 10.1016/S1474-4422(24)00097-8